FADS2 and neoplasm: In this study, we show that D6D, the rate-limiting enzyme for AA synthesis, is up-regulated in tumor tissues and that suppression of its expression or activity results in a remarkable reduction of tumor growth associated with a decrease in AA-derived eicosanoids, angiogenesis, and inflammation in tumor tissues.